A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

Condition: Multiple Sclerosis
Intervention: Drug: Ocrelizumab
Sponsor: Hoffmann-La Roche
Recruiting

Clinical Trials online